Psychiatry - Neuro/Psych Pharmacol News & Articles

521 Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial International Clinical Psychopharmacology, August 10, 2012    Clinical Article

522 Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission Neuropsychopharmacology, August 10, 2012    Clinical Article

523 Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam Epilepsia, August 10, 2012    Clinical Article

524 Attenuation of scopolamine-induced cognitive dysfunction by obovatol Full Text Archives of Pharmacal Research, August 9, 2012    Clinical Article

525 The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective European Journal of Clinical Pharmacology, August 9, 2012    Clinical Article

526 Use of antipsychotic medications in patients with Parkinson's disease at Auckland City Hospital Internal Medicine Journal, August 7, 2012    Clinical Article

527 Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics Journal of Clinical Pharmacy and Therapeutics, August 7, 2012    Clinical Article

528 Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia Medical Hypotheses, August 6, 2012    Clinical Article

529 Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP) Nephrology Dialysis Transplantation, August 6, 2012    Evidence Based Medicine    Clinical Article

530 Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study Full Text BMC Psychiatry, August 3, 2012    Clinical Article

531 The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia Human Psychopharmacology: Clinical and Experimental, August 2, 2012    Clinical Article

532 The Same Antidepressant Elicits Contrasting Patterns of Synaptic Changes in the Amygdala vs Hippocampus Neuropsychopharmacology, August 2, 2012    Clinical Article

533 Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression Biological Psychiatry, August 1, 2012    Clinical Article

534 Feasibility of Double-Blind Clinical Trials with Oral Diacetylmorphine: A Randomized Controlled Phase II Study in an Inpatient Setting European Addiction Research, August 1, 2012    Clinical Article

535 Syndrome of inappropriate secretion of antidiuretic hormone due to desvenlafaxine General Hospital Psychiatry, August 1, 2012

536 The cost-effectiveness of tailored, postal feedback on general practitioners prescribing of pharmacotherapies for alcohol dependence Drug and Alcohol Dependence, August 1, 2012

537 Prolongation of idiopathic thrombocytopenic purpura associated with paroxetine administration General Hospital Psychiatry, July 30, 2012

538 Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study European Neuropsychopharmacology, July 27, 2012    Clinical Article

539 Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far Schizophrenia Research, July 27, 2012    Clinical Article

540 Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the k Opioid Agonist Salvinorin A in Humans Biological Psychiatry, July 27, 2012    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013